Cerebrospinal Fluid Biomarker-Based Diagnosis of Sporadic Creutzfeldt-Jakob Disease: A Validation Study for Previously Established Cutoffs

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Dementia and Geriatric Cognitive Disorders

• Publication date

  2017-01-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000454802PMID 28056460
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Supplementary Material for: Cerebrospinal Fluid Biomarker-Based Diagnosis of Sporadic Creutzfeldt-Jakob Disease: A Validation Study for Previously Established Cutoffs

  2017cited by this paper
• Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia

  2016cited by this paper
• Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic

  2016cited by this paper
• CSF tau correlates with CJD disease severity and cognitive decline

  2016cited by this paper
• Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia

  2016cited by this paper
• Partial verification bias and incorporation bias affected accuracy estimates of diagnostic studies for biomarkers that were part of an existing composite gold standard.

  2016cited by this paper
• Stability and Reproducibility Underscore Utility of RT-QuIC for Diagnosis of Creutzfeldt-Jakob Disease

  2015cited by this paper
• Alternative application of Tau protein in Creutzfeldt-Jakob disease diagnosis: Improvement for weakly positive 14-3-3 protein in the laboratory

  2015cited by this paper
• Cerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease.

  2015cited by this paper
• Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.

  2015cited by this paper
• The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease

  2014cited by this paper
• Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry.

  2014cited by this paper
• Characteristic CSF Prion Seeding Efficiency in Humans with Prion Diseases

  2014cited by this paper
• Sporadic human prion diseases: molecular insights and diagnosis.

  2012cited by this paper
• Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA

  2012cited by this paper
• A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease

  2012cited by this paper
• Clinical Features of Rapidly Progressive Alzheimer’s Disease

  2010cited by this paper
• Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

  2009cited by this paper
• Total Tau Protein in Cerebrospinal Fluid and Diffusion-Weighted MRI as an Early Diagnostic Marker for Creutzfeldt-Jakob Disease

  2007cited by this paper
• Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis

  2007cited by this paper
• Enzyme-Linked Immunosorbent Assay

  2006cited by this paper
• CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease

  2006cited by this paper
• Follow-Up Investigations of Tau Protein and S-100B Levels in Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease

  2005cited by this paper
• Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease.

  2005cited by this paper
• Polymorphisms within the prion (PrP) and prion-like protein (Doppel) genes in AD

  2004cited by this paper
• A prospective study of CSF markers in 250 patients with possible Creutzfeldt–Jakob disease

  2003cited by this paper
• Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt–Jakob disease from other dementias

  2003cited by this paper
• Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt–Jakob disease

  2002cited by this paper
• Phosphorylated tau in cerebrospinal fluid as a marker for Creutzfeldt–Jakob disease

  2002cited by this paper
• Both total and phosphorylated tau are increased in Alzheimer's disease

  2001cited by this paper
• Detection of 14‐3‐3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt‐Jakob disease

  1998cited by this paper
• Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer’s disease: a community based follow up study

  1998cited by this paper
• The 14-3-3 brain protein and transmissible spongiform encephalopathy.

  1997cited by this paper
• Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

  1997cited by this paper
• The 14-3-3 brain protein and transmissible spongiform encephalopathy.

  1997cited by this paper
• The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease

  1997cited by this paper
• Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

  1995cited by this paper
• Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

  1993cited by this paper

• Cerebrospinal Fluid Biomarkers in Creutzfeldt–Jakob Disease: Diagnostic Value, Limitations, and Future Multi-Omics Strategies

  2026cites this paper
• A Systematic Review of Sporadic Creutzfeldt-Jakob Disease: Pathogenesis, Diagnosis, and Therapeutic Attempts

  2024influential citation
• Utilidad clínica de la proteína tau total y la ratio con su fracción fosforilada en el diagnóstico de enfermedad de Creutzfeldt-Jakob

  2023cites this paper
• Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?

  2022cites this paper
• Role of Biomarkers for the Diagnosis of Prion Diseases: A Narrative Review

  2022cites this paper
• Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer’s Disease

  2022cites this paper
• Biomarker-based diagnosis of sporadic Creutzfeldt-Jakob disease

  2021cites this paper
• Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease.

  2021cites this paper
• A prognostic model for overall survival in sporadic Creutzfeldt‐Jakob disease

  2020cites this paper
• Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias

  2020cites this paper
• Diagnostic Accuracy of Prion Disease Biomarkers in Iatrogenic Creutzfeldt-Jakob Disease

  2020cites this paper
• An automated alert system based on the p-Tau/Tau ratio to quickly inform health professionals upon a suspected case of sporadic Creutzfeldt-Jakob disease.

  2020cites this paper
• CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD

  2018cites this paper
• Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum

  2018cites this paper
• Tau Protein as a Biological Fluid Biomarker in Neurodegenerative Dementias

  2018cites this paper
• Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases

  2018cites this paper
• CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD

  2018cites this paper
• Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases

  2018cites this paper
• No added diagnostic value of non-phosphorylated tau fraction (p-taurel) in CSF as a biomarker for differential dementia diagnosis

  2017cites this paper
• Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease

  2017cites this paper
• YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias

  2017cites this paper
• Two Cases Report of Sporadic Creutzfeldt-Jakob Disease and Literature Review

  year unknowncites this paper